copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Visus closes in on AbbVie with midphase data on long-sightedness eye drop Visus’ eye drop is further back, but the phase 2 data point to the potential for it to deliver a differentiated candidate Notably, the midphase results provide early evidence in support of Visus’ framing of brimochol as a longer-lasting treatment Read the full article here
News - Visus Therapeutics™ Visus in the limelight As an active clinical-stage pharmaceutical company on the leading-edge of ophthalmic innovations, we’re bound to be making headlines Check back often for the very latest updates, announcements, and breakthroughs that are propelling us forward
Careers - Visus Therapeutics™ At Visus Therapeutics, we know that our people are the driving force behind the success of our mission and vision That’s why we aim to offer competitive employee benefits to attract the very best talent to our team: Generous medical, dental, and vision health insurance plans; Flexible spending accounts for health and dependent care
Visus Initiates Phase 3 Trial of Brimochol PF to Treat Presbyopia The first of two pivotal phase 3 trials that will assess the safety and efficacy of Brimochol PF for the treatment of presbyopia is underway, according to a press release from Visus Therapeutics